Cargando…
Drug memory reconsolidation: from molecular mechanisms to the clinical context
Since its rediscovery at the beginning of the 21(st) Century, memory reconsolidation has been proposed to be a therapeutic target for reducing the impact of emotional memories that can go awry in mental health disorders such as drug addiction (substance use disorder, SUD). Addiction can be conceptua...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692359/ https://www.ncbi.nlm.nih.gov/pubmed/38040677 http://dx.doi.org/10.1038/s41398-023-02666-1 |
_version_ | 1785152925777002496 |
---|---|
author | Milton, Amy L. |
author_facet | Milton, Amy L. |
author_sort | Milton, Amy L. |
collection | PubMed |
description | Since its rediscovery at the beginning of the 21(st) Century, memory reconsolidation has been proposed to be a therapeutic target for reducing the impact of emotional memories that can go awry in mental health disorders such as drug addiction (substance use disorder, SUD). Addiction can be conceptualised as a disorder of learning and memory, in which both pavlovian and instrumental learning systems become hijacked into supporting drug-seeking and drug-taking behaviours. The past two decades of research have characterised the details of the molecular pathways supporting the reconsolidation of pavlovian cue-drug memories, with more recent work indicating that the reconsolidation of instrumental drug-seeking memories also relies upon similar mechanisms. This narrative review considers what is known about the mechanisms underlying the reconsolidation of pavlovian and instrumental memories associated with drug use, how these approaches have translated to experimental medicine studies, and the challenges and opportunities for the clinical use of reconsolidation-based therapies. |
format | Online Article Text |
id | pubmed-10692359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106923592023-12-03 Drug memory reconsolidation: from molecular mechanisms to the clinical context Milton, Amy L. Transl Psychiatry Expert Review Since its rediscovery at the beginning of the 21(st) Century, memory reconsolidation has been proposed to be a therapeutic target for reducing the impact of emotional memories that can go awry in mental health disorders such as drug addiction (substance use disorder, SUD). Addiction can be conceptualised as a disorder of learning and memory, in which both pavlovian and instrumental learning systems become hijacked into supporting drug-seeking and drug-taking behaviours. The past two decades of research have characterised the details of the molecular pathways supporting the reconsolidation of pavlovian cue-drug memories, with more recent work indicating that the reconsolidation of instrumental drug-seeking memories also relies upon similar mechanisms. This narrative review considers what is known about the mechanisms underlying the reconsolidation of pavlovian and instrumental memories associated with drug use, how these approaches have translated to experimental medicine studies, and the challenges and opportunities for the clinical use of reconsolidation-based therapies. Nature Publishing Group UK 2023-12-01 /pmc/articles/PMC10692359/ /pubmed/38040677 http://dx.doi.org/10.1038/s41398-023-02666-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Expert Review Milton, Amy L. Drug memory reconsolidation: from molecular mechanisms to the clinical context |
title | Drug memory reconsolidation: from molecular mechanisms to the clinical context |
title_full | Drug memory reconsolidation: from molecular mechanisms to the clinical context |
title_fullStr | Drug memory reconsolidation: from molecular mechanisms to the clinical context |
title_full_unstemmed | Drug memory reconsolidation: from molecular mechanisms to the clinical context |
title_short | Drug memory reconsolidation: from molecular mechanisms to the clinical context |
title_sort | drug memory reconsolidation: from molecular mechanisms to the clinical context |
topic | Expert Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692359/ https://www.ncbi.nlm.nih.gov/pubmed/38040677 http://dx.doi.org/10.1038/s41398-023-02666-1 |
work_keys_str_mv | AT miltonamyl drugmemoryreconsolidationfrommolecularmechanismstotheclinicalcontext |